11C-Dihydrotetrabenazine PET of the Pancreas in Subjects with Long-Standing Type 1 Diabetes and in Healthy Controls-Reference-Cited by-同舟云学术

11C-Dihydrotetrabenazine PET of the Pancreas in Subjects with Long-Standing Type 1 Diabetes and in Healthy Controls

Published:2009-02-17 Issue:3 Volume:50 Page:382-389
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Goland Robin,Freeby Matthew,Parsey Ramin,Saisho Yoshifumi,Kumar Dileep,Simpson Norman,Hirsch Joy,Prince Martin,Maffei Antonella,Mann J. John,Butler Peter C.,Van Heertum Ronald,Leibel Rudolph L.,Ichise Masanori,Harris Paul E.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference32 articles.

1. Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes

2. Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis

3. Correlations of In Vivo β-Cell Function Tests With β-Cell Mass and Pancreatic Insulin Content in Streptozocin-Administered Baboons

4. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients

5. Advances in Male Contraception

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insights and Potential Therapeutic Interventions in Metabolic Diseases;International Journal of Molecular Sciences;2023-06-26

2. Polymer-Based Nanostructures for Pancreatic Beta-Cell Imaging and Non-Invasive Treatment of Diabetes;Pharmaceutics;2023-04-11

3. Noninvasive Quantitative PET Imaging in Humans of the Pancreatic Beta-Cell Mass Biomarkers VMAT2 and Dopamine D2/D3 Receptors In Vivo;Methods in Molecular Biology;2022-12-13

4. Single-cell RNA-seq transcriptomic landscape of human and mouse islets and pathological alterations of diabetes;iScience;2022-11

5. RNA aptamers specific for transmembrane p24 trafficking protein 6 and Clusterin for the targeted delivery of imaging reagents and RNA therapeutics to human β cells;Nature Communications;2022-04-05